019170 — SHINPOONG PHARMACEUTICAL CO Cashflow Statement
0.000.00%
Last trade - 00:00- KR₩375bn
- KR₩376bn
- KR₩221bn
Annual cashflow statement for SHINPOONG PHARMACEUTICAL CO, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 5,046 | -11,526 | -35,309 | -57,273 | -15,373 |
| Depreciation | |||||
| Amortisation | |||||
| Non-Cash Items | 9,789 | 1,659 | 6,863 | 17,719 | 3,256 |
| Unusual Items | |||||
| Equity in Net Earnings/Losses | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -6,981 | -73,837 | -10,801 | 2,798 | -15,000 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Net Change in Other Assets & Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 20,062 | -71,028 | -26,444 | -24,848 | -15,155 |
| Capital Expenditures | -3,120 | -5,615 | -6,229 | -15,031 | -6,089 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | -91,837 | 54,643 | 49,426 | -1,279 | 11,671 |
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Change in Net Investments | |||||
| Purchase of Investments | |||||
| Sale of Intangible Assets | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -94,957 | 49,028 | 43,197 | -16,309 | 5,583 |
| Financing Cash Flow Items | — | — | — | — | 40 |
| Other Financing Cash Flow | |||||
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 108,654 | -6,418 | -1,869 | 43,239 | 6,197 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 32,428 | -28,166 | 14,054 | 2,109 | -1,814 |